Trial Profile

The Efficacy and Safety of Winlevi in Skin of Color Patients With Acne

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 11 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clascoterone (Primary)
Indications Acne vulgaris
Focus Therapeutic Use
Sponsors Sun Pharmaceutical Industries

Most Recent Events

27 Feb 2026 According to a Sun Pharma media release, 52-week extended follow-up analysis will be presented at the 2026 Winter Clinical Miami on February 27-March 1, 2026 in Aventura, Florida.
07 May 2025 Status changed from active, no longer recruiting to completed.
25 Oct 2024 According to a Sun Pharma media release, company announced today , interim analysis 16-week data from this trial will be presented in a poster at the 44th Annual Fall Clinical Dermatology Conference, being held Oct 24-27, 2024, in Las Vegas, Nevada.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com